Similar articles

• Trimethoprim-sulfamethoxazole versus norfloxacin in the prophylaxis of spontaneous bacterial peritonitis in cirrhosis.

  Alvarez RF, Mattos AA, Corrêa EB, Cotrim HP, Nascimento TV. Alvarez RF, et al. Arq Gastroenterol. 2005 Oct-Dec;42(4):256-62. doi: 10.1590/s0004-28032005000400012. Epub 2006 Jan 19. Arq Gastroenterol. 2005. PMID: 16444382 Clinical Trial.
• Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial.

  Singh N, Gayowski T, Yu VL, Wagener MM. Singh N, et al. Ann Intern Med. 1995 Apr 15;122(8):595-8. doi: 10.7326/0003-4819-122-8-199504150-00007. Ann Intern Med. 1995. PMID: 7887554 Clinical Trial.
• [Primary prophylaxis of spontaneous bacterial peritonitis].

  Soriano G, Guarner C. Soriano G, et al. Gastroenterol Hepatol. 1997 Jun-Jul;20(6):312-4. Gastroenterol Hepatol. 1997. PMID: 9296848 Review. Spanish. No abstract available.
• Effect of long-term trimethoprim-sulfamethoxazole prophylaxis on ascites formation, bacterial translocation, spontaneous bacterial peritonitis, and survival in cirrhotic rats.

  Guarner C, Runyon BA, Heck M, Young S, Sheikh MY. Guarner C, et al. Dig Dis Sci. 1999 Oct;44(10):1957-62. doi: 10.1023/a:1026649730012. Dig Dis Sci. 1999. PMID: 10548343
• Role of Rifaximin in Spontaneous Bacterial Peritonitis Prevention.

  Oliver A, Wong M, Sanchez C. Oliver A, et al. South Med J. 2018 Nov;111(11):660-665. doi: 10.14423/SMJ.0000000000000887. South Med J. 2018. PMID: 30392000 Review.